Medical News Now title Secure5: How Secure5 works from our reliable partner source Medical Newswire title Security5 for free: How we can get it for free.source Medical NewSWire title Secure4: How secure 4 works from Medscape source Medical Daily title Secure 4: How it works from your trusted Medscape provider article Medscape Medical News article Secure4 (biolyze for life) is a new technology from the Biolyzer company that aims to bring life-saving treatments to those who are already in advanced stages of advanced cancer.
Biolyzer was founded by Dr. Andrew Pappas, M.D., Ph.
D. and Dr. Mark A. Gaffney, M.-B.S.C. to develop a life-preserving bio-technologies that will improve the quality of life for patients suffering from advanced and incurable cancers.
Bio.lyzer is designed to provide advanced treatments to patients suffering with advanced cancer or other malignancies, including the deadliest types of cancer.
The company has developed its proprietary bio-technology to help patients with advanced tumors to maintain a normal life and regain control of their body’s function.
The Bio.lyzers bio-tech works by creating new cells, called endothelial cells, that can repair and nourish the surrounding blood vessel wall and connect it to healthy nerves.
These cells then grow and multiply within the damaged tissue.
The goal of the bio-therapy is to give patients with cancer control of the stem cells that produce new blood vessels, allowing them to regain their function.
Dr. Andrew said, “The goal is to bring patients back to life, allowing us to restore the function of their diseased blood vessels and to help them live longer.”
“Biolyzers treatment is a proven technology that can be used in the treatment of many advanced cancers.
It can be administered through a patient’s own blood or through a system of implants and devices that is implanted in the body of a patient.
Patients who have received the Bio.lys technology have shown promising results in a number of clinical trials,” Dr. Pappis added.
Dr Mark Gaffey, M-B.
C., Ph,S., is the chief medical officer for Bio.LYZER.
He is a member of the board of directors for the BioLYZERS, Inc. He received his Ph.
D. in Chemistry from the University of Colorado Boulder and his B.
S in Biochemistry from Harvard Medical School.
Lyzer has been named one of the top 100 biotech startups in the United States.
BioLyzer is headquartered in Boulder, Colorado, with offices in Los Angeles and the Bay Area.